A vaccine combined with Keytruda is associated with a 49% reduction in the risk of recurrence or death. Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results